These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21061259)

  • 1. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
    Plant D; Bowes J; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; ; Barton A
    Arthritis Rheum; 2011 Mar; 63(3):645-53. PubMed ID: 21061259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis.
    Umiċeviċ Mirkov M; Cui J; Vermeulen SH; Stahl EA; Toonen EJ; Makkinje RR; Lee AT; Huizinga TW; Allaart R; Barton A; Mariette X; Miceli CR; Criswell LA; Tak PP; de Vries N; Saevarsdottir S; Padyukov L; Bridges SL; van Schaardenburg DJ; Jansen TL; Dutmer EA; van de Laar MA; Barrera P; Radstake TR; van Riel PL; Scheffer H; Franke B; Brunner HG; Plenge RM; Gregersen PK; Guchelaar HJ; Coenen MJ
    Ann Rheum Dis; 2013 Aug; 72(8):1375-81. PubMed ID: 23233654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?
    Verweij CL
    Nat Rev Rheumatol; 2011 Mar; 7(3):136-8. PubMed ID: 21304506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment.
    Tan RJ; Gibbons LJ; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Ann Rheum Dis; 2010 Jun; 69(6):1029-35. PubMed ID: 20444755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysis.
    Márquez A; Ferreiro-Iglesias A; Dávila-Fajardo CL; Montes A; Pascual-Salcedo D; Perez-Pampin E; Moreno-Ramos MJ; García-Portales R; Navarro F; Moreira V; Magro C; Caliz R; Ferrer MA; Alegre-Sancho JJ; Joven B; Carreira P; Balsa A; Vasilopoulos Y; Sarafidou T; Cabeza-Barrera J; Narvaez J; Raya E; Cañete JD; Fernández-Nebro A; Ordóñez Mdel C; de la Serna AR; Magallares B; Gomez-Reino JJ; González A; Martín J
    Arthritis Res Ther; 2014 Mar; 16(2):R66. PubMed ID: 24612463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort.
    Plant D; Prajapati R; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; Barton A
    Arthritis Rheum; 2012 Mar; 64(3):665-70. PubMed ID: 21952740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.
    Honne K; Hallgrímsdóttir I; Wu C; Sebro R; Jewell NP; Sakurai T; Iwamoto M; Minota S; Jawaheer D
    Arthritis Res Ther; 2016 Jan; 18():12. PubMed ID: 26776603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis.
    Sode J; Vogel U; Bank S; Andersen PS; Hetland ML; Locht H; Heegaard NH; Andersen V
    PLoS One; 2015; 10(10):e0139781. PubMed ID: 26440629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study.
    Suarez-Gestal M; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Res Ther; 2010; 12(2):R72. PubMed ID: 20423481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis.
    Julià A; Fernandez-Nebro A; Blanco F; Ortiz A; Cañete JD; Maymó J; Alperi-López M; Fernández-Gutierrez B; Olivè A; Corominas H; Erra A; Acosta-Colman I; Alonso A; López-Lasanta M; Tortosa R; Tornero J; Marsal S
    Pharmacogenomics J; 2016 Apr; 16(2):147-50. PubMed ID: 25896534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.
    Liu C; Batliwalla F; Li W; Lee A; Roubenoff R; Beckman E; Khalili H; Damle A; Kern M; Furie R; Dupuis J; Plenge RM; Coenen MJ; Behrens TW; Carulli JP; Gregersen PK
    Mol Med; 2008; 14(9-10):575-81. PubMed ID: 18615156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
    Sánchez-Maldonado JM; Cáliz R; López-Nevot MÁ; Cabrera-Serrano AJ; Moñiz-Díez A; Canhão H; Ter Horst R; Quartuccio L; Sorensen SB; Glintborg B; Hetland ML; Filipescu I; Pérez-Pampin E; Conesa-Zamora P; Swierkot J; den Broeder AA; De Vita S; Petersen ERB; Li Y; Ferrer MA; Escudero A; Netea MG; Coenen MJH; Andersen V; Fonseca JE; Jurado M; Bogunia-Kubik K; Collantes E; Sainz J
    Front Immunol; 2021; 12():672255. PubMed ID: 34777329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GWAS replication study confirms the association of PDE3A-SLCO1C1 with anti-TNF therapy response in rheumatoid arthritis.
    Acosta-Colman I; Palau N; Tornero J; Fernández-Nebro A; Blanco F; González-Alvaro I; Cañete JD; Maymó J; Ballina J; Fernández-Gutiérrez B; Olivé A; Corominas H; Erra A; Canela-Xandri O; Alonso A; López Lasanta M; Tortosa R; Julià A; Marsal S
    Pharmacogenomics; 2013 May; 14(7):727-34. PubMed ID: 23651021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
    Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
    Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of single nucleotide polymorphisms and biological pathways associated with response to TNFα inhibitors in patients with rheumatoid arthritis.
    Krintel SB; Palermo G; Johansen JS; Germer S; Essioux L; Benayed R; Badi L; Ostergaard M; Hetland ML
    Pharmacogenet Genomics; 2012 Aug; 22(8):577-89. PubMed ID: 22569225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility.
    Julià A; Ballina J; Cañete JD; Balsa A; Tornero-Molina J; Naranjo A; Alperi-López M; Erra A; Pascual-Salcedo D; Barceló P; Camps J; Marsal S
    Arthritis Rheum; 2008 Aug; 58(8):2275-86. PubMed ID: 18668548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
    Canet LM; Sánchez-Maldonado JM; Cáliz R; Rodríguez-Ramos A; Lupiañez CB; Canhão H; Martínez-Bueno M; Escudero A; Segura-Catena J; Sorensen SB; Hetland ML; Soto-Pino MJ; Ferrer MA; García A; Glintborg B; Filipescu I; Pérez-Pampin E; González-Utrilla A; Nevot MÁL; Conesa-Zamora P; Broeder AD; De Vita S; Jacobsen SEH; Collantes-Estevez E; Quartuccio L; Canzian F; Fonseca JE; Coenen MJH; Andersen V; Sainz J
    Pharmacogenomics J; 2019 Feb; 19(1):83-96. PubMed ID: 30287909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept.
    Ferreiro-Iglesias A; Montes A; Perez-Pampin E; Cañete JD; Raya E; Magro-Checa C; Vasilopoulos Y; Caliz R; Ferrer MA; Joven B; Carreira P; Balsa A; Pascual-Salcedo D; Blanco FJ; Moreno-Ramos MJ; Manrique-Arija S; Ordoñez MDC; Alegre-Sancho JJ; Narvaez J; Navarro-Sarabia F; Moreira V; Valor L; Garcia-Portales R; Marquez A; Gomez-Reino JJ; Martin J; Gonzalez A
    PLoS One; 2019; 14(2):e0213073. PubMed ID: 30818333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variants within the TNFRSF1B gene and susceptibility to rheumatoid arthritis and response to anti-TNF drugs: a multicenter study.
    Canet LM; Filipescu I; Cáliz R; Lupiañez CB; Canhão H; Escudero A; Segura-Catena J; Soto-Pino MJ; Ferrer MA; García A; Romani L; Pérez-Pampin E; González-Utrilla A; López Nevot MA; Collantes E; Fonseca JE; Sainz J
    Pharmacogenet Genomics; 2015 Jul; 25(7):323-33. PubMed ID: 25850964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.